Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8322 |
Intermediate Similarity |
NPD5546 |
Clinical (unspecified phase) |
0.7972 |
Intermediate Similarity |
NPD6506 |
Clinical (unspecified phase) |
0.7902 |
Intermediate Similarity |
NPD6301 |
Phase 2 |
0.7899 |
Intermediate Similarity |
NPD1316 |
Discontinued |
0.7801 |
Intermediate Similarity |
NPD3864 |
Clinical (unspecified phase) |
0.7737 |
Intermediate Similarity |
NPD995 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD184 |
Approved |
0.7638 |
Intermediate Similarity |
NPD1108 |
Approved |
0.7638 |
Intermediate Similarity |
NPD1107 |
Approved |
0.7635 |
Intermediate Similarity |
NPD1664 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD1226 |
Approved |
0.7466 |
Intermediate Similarity |
NPD1908 |
Phase 2 |
0.7413 |
Intermediate Similarity |
NPD2791 |
Discontinued |
0.7343 |
Intermediate Similarity |
NPD1106 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD3883 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD5989 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD1595 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1594 |
Phase 3 |
0.7266 |
Intermediate Similarity |
NPD993 |
Approved |
0.7266 |
Intermediate Similarity |
NPD990 |
Approved |
0.7255 |
Intermediate Similarity |
NPD2188 |
Approved |
0.7255 |
Intermediate Similarity |
NPD2882 |
Phase 1 |
0.7218 |
Intermediate Similarity |
NPD1813 |
Discontinued |
0.7214 |
Intermediate Similarity |
NPD2840 |
Approved |
0.7206 |
Intermediate Similarity |
NPD2210 |
Approved |
0.7206 |
Intermediate Similarity |
NPD2212 |
Approved |
0.719 |
Intermediate Similarity |
NPD2328 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD1592 |
Phase 3 |
0.7181 |
Intermediate Similarity |
NPD4430 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD7735 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD2470 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD1397 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1305 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1325 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6320 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1326 |
Approved |
0.7124 |
Intermediate Similarity |
NPD1405 |
Approved |
0.7117 |
Intermediate Similarity |
NPD5153 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD2468 |
Approved |
0.7115 |
Intermediate Similarity |
NPD2469 |
Approved |
0.7107 |
Intermediate Similarity |
NPD5138 |
Approved |
0.7107 |
Intermediate Similarity |
NPD5140 |
Approved |
0.709 |
Intermediate Similarity |
NPD5631 |
Phase 3 |
0.7083 |
Intermediate Similarity |
NPD865 |
Approved |
0.7083 |
Intermediate Similarity |
NPD864 |
Approved |
0.7078 |
Intermediate Similarity |
NPD3329 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD1764 |
Approved |
0.7068 |
Intermediate Similarity |
NPD1762 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6359 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD7481 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7480 |
Approved |
0.7054 |
Intermediate Similarity |
NPD563 |
Approved |
0.7054 |
Intermediate Similarity |
NPD564 |
Approved |
0.7032 |
Intermediate Similarity |
NPD6476 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD6158 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD3587 |
Clinical (unspecified phase) |
0.7015 |
Intermediate Similarity |
NPD3149 |
Approved |
0.7015 |
Intermediate Similarity |
NPD2659 |
Approved |
0.7015 |
Intermediate Similarity |
NPD2658 |
Approved |
0.7015 |
Intermediate Similarity |
NPD3147 |
Approved |
0.7015 |
Intermediate Similarity |
NPD3150 |
Approved |
0.7015 |
Intermediate Similarity |
NPD3148 |
Approved |
0.7014 |
Intermediate Similarity |
NPD1001 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD964 |
Approved |
0.6981 |
Remote Similarity |
NPD6524 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD6522 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD1235 |
Phase 3 |
0.6977 |
Remote Similarity |
NPD5042 |
Phase 1 |
0.6944 |
Remote Similarity |
NPD4019 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD3625 |
Discontinued |
0.6923 |
Remote Similarity |
NPD5663 |
Discontinued |
0.6919 |
Remote Similarity |
NPD1043 |
Phase 3 |
0.6912 |
Remote Similarity |
NPD2622 |
Approved |
0.6909 |
Remote Similarity |
NPD5065 |
Approved |
0.6905 |
Remote Similarity |
NPD7867 |
Phase 1 |
0.6899 |
Remote Similarity |
NPD2789 |
Approved |
0.6897 |
Remote Similarity |
NPD4274 |
Approved |
0.6897 |
Remote Similarity |
NPD3720 |
Discontinued |
0.6897 |
Remote Similarity |
NPD4275 |
Approved |
0.6894 |
Remote Similarity |
NPD2678 |
Approved |
0.6894 |
Remote Similarity |
NPD2679 |
Approved |
0.689 |
Remote Similarity |
NPD4150 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD3824 |
Phase 1 |
0.689 |
Remote Similarity |
NPD4083 |
Discontinued |
0.6875 |
Remote Similarity |
NPD5599 |
Discontinued |
0.6867 |
Remote Similarity |
NPD2380 |
Approved |
0.6867 |
Remote Similarity |
NPD2382 |
Approved |
0.6867 |
Remote Similarity |
NPD2381 |
Approved |
0.6866 |
Remote Similarity |
NPD2999 |
Approved |
0.6866 |
Remote Similarity |
NPD3001 |
Approved |
0.6859 |
Remote Similarity |
NPD3277 |
Phase 3 |
0.6842 |
Remote Similarity |
NPD1625 |
Approved |
0.6836 |
Remote Similarity |
NPD5856 |
Discontinued |
0.6835 |
Remote Similarity |
NPD1306 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD4871 |
Phase 2 |
0.6818 |
Remote Similarity |
NPD2243 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD9715 |
Phase 2 |
0.6812 |
Remote Similarity |
NPD9247 |
Phase 3 |
0.6797 |
Remote Similarity |
NPD2387 |
Approved |
0.6794 |
Remote Similarity |
NPD414 |
Discontinued |
0.6781 |
Remote Similarity |
NPD4866 |
Approved |
0.6781 |
Remote Similarity |
NPD4867 |
Approved |
0.6781 |
Remote Similarity |
NPD3841 |
Phase 3 |
0.6776 |
Remote Similarity |
NPD1189 |
Approved |
0.6761 |
Remote Similarity |
NPD478 |
Approved |
0.6757 |
Remote Similarity |
NPD7200 |
Approved |
0.6753 |
Remote Similarity |
NPD3813 |
Approved |
0.6753 |
Remote Similarity |
NPD5595 |
Clinical (unspecified phase) |
0.6752 |
Remote Similarity |
NPD4462 |
Approved |
0.6752 |
Remote Similarity |
NPD4463 |
Approved |
0.6752 |
Remote Similarity |
NPD2398 |
Phase 3 |
0.675 |
Remote Similarity |
NPD4670 |
Clinical (unspecified phase) |
0.675 |
Remote Similarity |
NPD4671 |
Clinical (unspecified phase) |
0.675 |
Remote Similarity |
NPD4669 |
Clinical (unspecified phase) |
0.6748 |
Remote Similarity |
NPD3363 |
Clinical (unspecified phase) |
0.6746 |
Remote Similarity |
NPD6833 |
Clinical (unspecified phase) |
0.6744 |
Remote Similarity |
NPD706 |
Phase 1 |
0.6739 |
Remote Similarity |
NPD2463 |
Approved |
0.6739 |
Remote Similarity |
NPD2464 |
Approved |
0.6739 |
Remote Similarity |
NPD2467 |
Approved |
0.6738 |
Remote Similarity |
NPD1236 |
Phase 3 |
0.6736 |
Remote Similarity |
NPD6900 |
Discontinued |
0.6731 |
Remote Similarity |
NPD4888 |
Discontinued |
0.6731 |
Remote Similarity |
NPD5881 |
Clinical (unspecified phase) |
0.6731 |
Remote Similarity |
NPD4703 |
Approved |
0.6731 |
Remote Similarity |
NPD4702 |
Approved |
0.6728 |
Remote Similarity |
NPD1685 |
Approved |
0.6728 |
Remote Similarity |
NPD1684 |
Approved |
0.6724 |
Remote Similarity |
NPD5117 |
Phase 2 |
0.6718 |
Remote Similarity |
NPD179 |
Clinical (unspecified phase) |
0.6718 |
Remote Similarity |
NPD1728 |
Clinical (unspecified phase) |
0.6716 |
Remote Similarity |
NPD1539 |
Approved |
0.6712 |
Remote Similarity |
NPD1271 |
Clinical (unspecified phase) |
0.671 |
Remote Similarity |
NPD5839 |
Clinical (unspecified phase) |
0.6708 |
Remote Similarity |
NPD4860 |
Clinical (unspecified phase) |
0.6708 |
Remote Similarity |
NPD6283 |
Phase 2 |
0.6708 |
Remote Similarity |
NPD4514 |
Approved |
0.6707 |
Remote Similarity |
NPD1965 |
Approved |
0.6707 |
Remote Similarity |
NPD6767 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD6316 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD6492 |
Phase 2 |
0.6705 |
Remote Similarity |
NPD5428 |
Discontinued |
0.6692 |
Remote Similarity |
NPD1417 |
Approved |
0.6692 |
Remote Similarity |
NPD1419 |
Approved |
0.6691 |
Remote Similarity |
NPD313 |
Approved |
0.669 |
Remote Similarity |
NPD2173 |
Clinical (unspecified phase) |
0.6689 |
Remote Similarity |
NPD2003 |
Phase 1 |
0.6687 |
Remote Similarity |
NPD2215 |
Approved |
0.6687 |
Remote Similarity |
NPD2216 |
Approved |
0.6667 |
Remote Similarity |
NPD4999 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD9587 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD5596 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD4998 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD2583 |
Phase 2 |
0.6646 |
Remote Similarity |
NPD212 |
Discontinued |
0.6645 |
Remote Similarity |
NPD2887 |
Clinical (unspecified phase) |
0.6645 |
Remote Similarity |
NPD6606 |
Clinical (unspecified phase) |
0.6644 |
Remote Similarity |
NPD2036 |
Approved |
0.6644 |
Remote Similarity |
NPD9284 |
Approved |
0.6644 |
Remote Similarity |
NPD9080 |
Approved |
0.6642 |
Remote Similarity |
NPD477 |
Phase 1 |
0.6641 |
Remote Similarity |
NPD2244 |
Clinical (unspecified phase) |
0.6623 |
Remote Similarity |
NPD6636 |
Phase 3 |
0.6623 |
Remote Similarity |
NPD4077 |
Clinical (unspecified phase) |
0.6623 |
Remote Similarity |
NPD4411 |
Phase 1 |
0.6623 |
Remote Similarity |
NPD4410 |
Clinical (unspecified phase) |
0.6617 |
Remote Similarity |
NPD1064 |
Approved |
0.6617 |
Remote Similarity |
NPD1065 |
Approved |
0.6611 |
Remote Similarity |
NPD3814 |
Phase 1 |
0.6609 |
Remote Similarity |
NPD6141 |
Clinical (unspecified phase) |
0.6605 |
Remote Similarity |
NPD5255 |
Approved |
0.6605 |
Remote Similarity |
NPD4485 |
Approved |
0.6605 |
Remote Similarity |
NPD6060 |
Clinical (unspecified phase) |
0.6605 |
Remote Similarity |
NPD1554 |
Clinical (unspecified phase) |
0.6604 |
Remote Similarity |
NPD6707 |
Clinical (unspecified phase) |
0.6604 |
Remote Similarity |
NPD3248 |
Phase 1 |
0.6604 |
Remote Similarity |
NPD5267 |
Discontinued |
0.6603 |
Remote Similarity |
NPD3278 |
Clinical (unspecified phase) |
0.6601 |
Remote Similarity |
NPD6789 |
Approved |
0.6601 |
Remote Similarity |
NPD9477 |
Approved |
0.66 |
Remote Similarity |
NPD3851 |
Clinical (unspecified phase) |
0.6591 |
Remote Similarity |
NPD311 |
Approved |
0.6591 |
Remote Similarity |
NPD310 |
Approved |
0.6591 |
Remote Similarity |
NPD5641 |
Discontinued |
0.6591 |
Remote Similarity |
NPD10 |
Approved |
0.6591 |
Remote Similarity |
NPD309 |
Approved |
0.6591 |
Remote Similarity |
NPD314 |
Approved |
0.6591 |
Remote Similarity |
NPD315 |
Approved |
0.6587 |
Remote Similarity |
NPD5680 |
Clinical (unspecified phase) |
0.6584 |
Remote Similarity |
NPD7091 |
Discontinued |
0.6581 |
Remote Similarity |
NPD3717 |
Discontinued |
0.6581 |
Remote Similarity |
NPD3016 |
Clinical (unspecified phase) |
0.6579 |
Remote Similarity |
NPD1626 |
Approved |
0.6573 |
Remote Similarity |
NPD2131 |
Approved |
0.6567 |
Remote Similarity |
NPD4115 |
Approved |
0.6567 |
Remote Similarity |
NPD4114 |
Approved |
0.6558 |
Remote Similarity |
NPD1649 |
Discontinued |
0.6554 |
Remote Similarity |
NPD6887 |
Clinical (unspecified phase) |
0.6554 |
Remote Similarity |
NPD1070 |
Approved |
0.6554
|
Remote Similarity |
NPD3404 |
Approved |